tetano
Editor, Senior Moderator
J Pediatric Infect Dis Soc. 2016 Dec;5(4):349-355. Epub 2016 Oct 7.
[h=1]Update From the Advisory Committee on Immunization Practices.[/h] Schuster JE[SUP]1[/SUP], O'Leary S[SUP]2[/SUP], Kimberlin DW[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Advisory Committee on Immunization Practices (ACIP) consists of medical and public health experts who develop recommendations on vaccine use in the United States. The ACIP meets 3 times per year, and members and Centers for Disease Control (CDC) staff present findings and discuss vaccine research, vaccine effectiveness (VE) and safety, clinical trial results, and labeling/package insert information. Outbreaks of vaccine-preventable diseases and vaccine shortages are also discussed. Nonvoting representatives from the American Academy of Pediatrics and the Pediatric Infectious Diseases Society are present. The ACIP met on June 22-23, 2016 to discuss proposed recommendations for influenza vaccination, for human papillomavirus (HPV) vaccine dosing schedules, for the cholera vaccine (CVD 103-HgR), and for the use of MenACWY in human immunodeficiency virus (HIV)-infected persons, as well as an overview of respiratory syncytial virus (RSV) vaccines, safety of maternal tetanus, diphtheria, acellular pertussis (Tdap) immunization, and laboratory containment of poliovirus type 2.
? The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
[h=4]KEYWORDS:[/h] ACIP; CDC; immunization
PMID: 27856770 DOI: 10.1093/jpids/piw057
[PubMed - in process]
[h=1]Update From the Advisory Committee on Immunization Practices.[/h] Schuster JE[SUP]1[/SUP], O'Leary S[SUP]2[/SUP], Kimberlin DW[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Advisory Committee on Immunization Practices (ACIP) consists of medical and public health experts who develop recommendations on vaccine use in the United States. The ACIP meets 3 times per year, and members and Centers for Disease Control (CDC) staff present findings and discuss vaccine research, vaccine effectiveness (VE) and safety, clinical trial results, and labeling/package insert information. Outbreaks of vaccine-preventable diseases and vaccine shortages are also discussed. Nonvoting representatives from the American Academy of Pediatrics and the Pediatric Infectious Diseases Society are present. The ACIP met on June 22-23, 2016 to discuss proposed recommendations for influenza vaccination, for human papillomavirus (HPV) vaccine dosing schedules, for the cholera vaccine (CVD 103-HgR), and for the use of MenACWY in human immunodeficiency virus (HIV)-infected persons, as well as an overview of respiratory syncytial virus (RSV) vaccines, safety of maternal tetanus, diphtheria, acellular pertussis (Tdap) immunization, and laboratory containment of poliovirus type 2.
? The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
[h=4]KEYWORDS:[/h] ACIP; CDC; immunization
PMID: 27856770 DOI: 10.1093/jpids/piw057
[PubMed - in process]